METAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.832600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.699200E-01
Normal-vs-Stage2
5.380400E-01
Normal-vs-Stage3
4.067800E-01
Normal-vs-Stage4
6.723200E-01
Stage1-vs-Stage2
5.921200E-01
Stage1-vs-Stage3
3.923800E-01
Stage1-vs-Stage4
4.363800E-01
Stage2-vs-Stage3
5.950000E-01
Stage2-vs-Stage4
1.624650E-01
Stage3-vs-Stage4
2.802200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.931600E-01
Normal-vs-AfricanAmerican
8.807800E-01
Normal-vs-Asian
1.611570E-01
Caucasian-vs-AfricanAmerican
6.477000E-01
Caucasian-vs-Asian
1.492620E-01
AfricanAmerican-vs-Asian
2.146000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.182400E-01
Normal-vs-Female
5.488200E-01
Male-vs-Female
9.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.414800E-01
Normal-vs-Age(41-60Yrs)
9.124800E-01
Normal-vs-Age(61-80Yrs)
4.409400E-01
Normal-vs-Age(81-100Yrs)
7.451200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.263000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.283200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.873200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.556480E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.967400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.492600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.936040E-01
Normal-vs-Daily Drinker
2.617200E-01
Normal-vs-Weekly Drinker
4.099800E-01
Normal-vs-Occasional Drinker
9.187000E-01
Normal-vs-Social Drinker
6.085800E-01
Non Drinker-vs-Daily Drinker
9.388400E-01
Non Drinker-vs-Weekly Drinker
7.513000E-01
Non Drinker-vs-Occasional Drinker
1.173880E-02
Non Drinker-vs-Social Drinker
3.112800E-01
Daily Drinker-vs-Weekly Drinker
7.448400E-01
Daily Drinker-vs-Occasional Drinker
2.654000E-02
Daily Drinker-vs-Social Drinker
3.577000E-01
Weekly Drinker-vs-Occasional Drinker
1.096650E-01
Weekly Drinker-vs-Social Drinker
6.152200E-01
Occasional Drinker-vs-Social Drinker
2.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.237800E-01
Normal-vs-Grade 2
7.009800E-01
Normal-vs-Grade 3
7.009600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.919400E-01
Grade 1-vs-Grade 3
5.396600E-01
Grade 1-vs-Grade 4
4.237800E-01
Grade 2-vs-Grade 3
9.926200E-01
Grade 2-vs-Grade 4
7.009800E-01
Grade 3-vs-Grade 4
7.009600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.634800E-01
Normal-vs-NonDiabetic
4.089400E-01
Diabetic-vs-NonDiabetic
8.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.165420E-01
Normal-vs-NoPancreatitis
5.055400E-01
Pancreatitis-vs-NoPancreatitis
1.176640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.676200E-01
Normal-vs-N1
5.680400E-01
N0-vs-N1
5.741200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.737400E-01
Normal-vs-TP53-NonMutant
7.679400E-01
TP53-Mutant-vs-TP53-NonMutant
9.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
